Team:Hannover/Primer

From 2014.igem.org

(Difference between revisions)
 
(6 intermediate revisions not shown)
Line 5: Line 5:
<html>
<html>
<body>
<body>
-
<h1>Primer</h1><p class="text"> Here you find a list that includes every used primer.</p>
+
<h1><a href="https://2014.igem.org/Team:Hannover/Protocols">Protocols</a> / Primer</h1><p class="text"> Here you find a list including the oligonucleotides used.</p>
 +
<center>
<table>
<table>
<colgroup>
<colgroup>
Line 11: Line 12:
<col width=600>
<col width=600>
</colgroup>
</colgroup>
-
<tr><td><b>name</b></td><td><b>sequence in 5' &rarr; 3' direction</b></td></tr>
+
<tr><td><b>Name</b></td><td><b><p class="text" >Sequence in 5' &rarr; 3' Direction</p></b></td></tr>
-
<tr><td>01_pORE_E3_2x35S fwd</td><td>agcgtcggcgaggctaaaaagaacaaatgt</td></tr>
+
<tr><td>01_pORE_E3_2x35S fwd</td><td><p class="text" style="text-transform:lowercase;">agcgtcggcgaggctaaaaagaacaaatgt</p></td></tr>
-
<tr><td>02_pORE_E3_2x35S rev</td><td><p class="text" style="text-transform:lowercase;">ggaaGGATCCCTCTCCAAATGAAATGAACTTCCTTATATAGAGGAA</p></p></td></tr>
+
<tr><td>02_pORE_E3_2x35S rev</td><td><p class="text" style="text-transform:lowercase;">ggaaGGATCCCTCTCCAAATGAAATGAACTTCCTTATATAGAGGAA</p></td></tr>
<tr><td>03_Oligo1_RCF[21]</td><td><p class="text" style="text-transform:lowercase;">GATCGAATTCAGATCTGGATCCtaaCTCGAG</p></td></tr>
<tr><td>03_Oligo1_RCF[21]</td><td><p class="text" style="text-transform:lowercase;">GATCGAATTCAGATCTGGATCCtaaCTCGAG</p></td></tr>
<tr><td>04_Oligo2_RCF[21]</td><td><p class="text" style="text-transform:lowercase;">CGCGCTCGAGttaGGATCCAGATCTGAATTC</p></td></tr>
<tr><td>04_Oligo2_RCF[21]</td><td><p class="text" style="text-transform:lowercase;">CGCGCTCGAGttaGGATCCAGATCTGAATTC</p></td></tr>
<tr><td>05_F1_gfp_EMP</td><td><p class="text" style="text-transform:lowercase;">AGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTC</p></td></tr>
<tr><td>05_F1_gfp_EMP</td><td><p class="text" style="text-transform:lowercase;">AGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTC</p></td></tr>
<tr><td>06_R1_gfp_EMP</td><td><p class="text" style="text-transform:lowercase;">CCGGACTTGTCATCGTCGTCCTTGTAGTCTTTGTATAGTTCATCCATGCCATGTGTAATCCCAG</p></td></tr>
<tr><td>06_R1_gfp_EMP</td><td><p class="text" style="text-transform:lowercase;">CCGGACTTGTCATCGTCGTCCTTGTAGTCTTTGTATAGTTCATCCATGCCATGTGTAATCCCAG</p></td></tr>
-
<tr><td>07_R2_gfp_EMP</td><td>agcgtcggcgaggctaaaaagaacaaatgt</p></td></tr>
+
<tr><td>07_R2_gfp_EMP</td><td><p class="text" style="text-transform:lowercase;">agcgtcggcgaggctaaaaagaacaaatgt</p></td></tr>
<tr><td>08_TMBP_pASK_fwd</td><td><p class="text" style="text-transform:lowercase;">ggaaGAATTCgGACGAtGATGAtAAGGTGGTTATCAACGGCGTCAAGT</p></td></tr>
<tr><td>08_TMBP_pASK_fwd</td><td><p class="text" style="text-transform:lowercase;">ggaaGAATTCgGACGAtGATGAtAAGGTGGTTATCAACGGCGTCAAGT</p></td></tr>
<tr><td>09_TMBP_pASK_rev</td><td><p class="text" style="text-transform:lowercase;">ggaaCCATGGgtTTGTCgTCGTCaTCCTTACAGCTGCAAGATGATCCGC</p></td></tr>
<tr><td>09_TMBP_pASK_rev</td><td><p class="text" style="text-transform:lowercase;">ggaaCCATGGgtTTGTCgTCGTCaTCCTTACAGCTGCAAGATGATCCGC</p></td></tr>
Line 27: Line 28:
<tr><td>14_CBD in pSB1C3 fwd</td><td><p class="text" style="text-transform:lowercase;">aaGAATTCGCGGCCGCTTCTAGATGACCAGTTCTATGTCAGTAGAATTTT</p></td></tr>
<tr><td>14_CBD in pSB1C3 fwd</td><td><p class="text" style="text-transform:lowercase;">aaGAATTCGCGGCCGCTTCTAGATGACCAGTTCTATGTCAGTAGAATTTT</p></td></tr>
<tr><td>15_CBD in pSB1C3 rev</td><td><p class="text" style="text-transform:lowercase;">aaCTGCAGCGGCCGCTACTAGTAttattaaCGGCCTGACGCAAATCC</p></td></tr>
<tr><td>15_CBD in pSB1C3 rev</td><td><p class="text" style="text-transform:lowercase;">aaCTGCAGCGGCCGCTACTAGTAttattaaCGGCCTGACGCAAATCC</p></td></tr>
-
<tr><td>16_VF2</td><td>tgccacctgacgtctaagaa</td></tr>
+
<tr><td>16_VF2</td><td><p class="text" style="text-transform:lowercase;">tgccacctgacgtctaagaa</p></td></tr>
-
<tr><td>17_VR</td><td>attaccgcctttgagtgagc</td></tr>
+
<tr><td>17_VR</td><td><p class="text" style="text-transform:lowercase;">attaccgcctttgagtgagc</p></td></tr>
<tr><td>T7</td><td><p class="text" style="text-transform:lowercase;">CGACTCACTATAGGGCG</p></td></tr>
<tr><td>T7</td><td><p class="text" style="text-transform:lowercase;">CGACTCACTATAGGGCG</p></td></tr>
<tr><td>BackSeq-pGII</td><td><p class="text" style="text-transform:lowercase;">attaccggcctttgagtgagc</p></td></tr>
<tr><td>BackSeq-pGII</td><td><p class="text" style="text-transform:lowercase;">attaccggcctttgagtgagc</p></td></tr>
</table>
</table>
-
 
+
</center>
-
 
+
</body>
</body>
</html>
</html>

Latest revision as of 23:36, 17 October 2014

Protocols / Primer

Here you find a list including the oligonucleotides used.

Name

Sequence in 5' → 3' Direction

01_pORE_E3_2x35S fwd

agcgtcggcgaggctaaaaagaacaaatgt

02_pORE_E3_2x35S rev

ggaaGGATCCCTCTCCAAATGAAATGAACTTCCTTATATAGAGGAA

03_Oligo1_RCF[21]

GATCGAATTCAGATCTGGATCCtaaCTCGAG

04_Oligo2_RCF[21]

CGCGCTCGAGttaGGATCCAGATCTGAATTC

05_F1_gfp_EMP

AGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTC

06_R1_gfp_EMP

CCGGACTTGTCATCGTCGTCCTTGTAGTCTTTGTATAGTTCATCCATGCCATGTGTAATCCCAG

07_R2_gfp_EMP

agcgtcggcgaggctaaaaagaacaaatgt

08_TMBP_pASK_fwd

ggaaGAATTCgGACGAtGATGAtAAGGTGGTTATCAACGGCGTCAAGT

09_TMBP_pASK_rev

ggaaCCATGGgtTTGTCgTCGTCaTCCTTACAGCTGCAAGATGATCCGC

10_Expa4 in pSB1C3 fwd

aaGAATTCGCGGCCGCTTCTAGatggctattaaactagcaattc

11_Expa4 in pSB1C3 rev

aaCTGCAGCGGCCGCTACTAGTAagcgtcggcgaggct

12_TMBP in pSB1C3 fwd

aaGAATTCGCGGCCGCTTCTAGATGGTGGTTATCAACGGCGTCAAGT

13_TMBP in pSB1C3 rev

aaCTGCAGCGGCCGCTACTAGTAttattaCTTACAGCTGCAAGATGATCCGC

14_CBD in pSB1C3 fwd

aaGAATTCGCGGCCGCTTCTAGATGACCAGTTCTATGTCAGTAGAATTTT

15_CBD in pSB1C3 rev

aaCTGCAGCGGCCGCTACTAGTAttattaaCGGCCTGACGCAAATCC

16_VF2

tgccacctgacgtctaagaa

17_VR

attaccgcctttgagtgagc

T7

CGACTCACTATAGGGCG

BackSeq-pGII

attaccggcctttgagtgagc